STERIS plc (STE)
Health Care / Health Care Equipment
S&P 500$202.78
Below average on several measures. Research carefully.
Weak
Score based on 5 of 5 models — high confidence
Is STERIS plc a Good Investment in 2026?
STERIS plc (STE) scores 4.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates STERIS plc as Strong (8/9). The Greenblatt Magic Formula model is the least favorable, rating it Neutral. STERIS plc currently trades above its estimated fair value of $194, suggesting limited upside at current prices. STERIS plc ranks #770 out of 1123 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading near estimated fair value.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
8/9
Buffett
Attractive
Business quality & competitive moat
Graham
Neutral
87% above fair value
Lynch
Neutral
PEG 1.2 · Fast Grower
Greenblatt
Neutral
Top half (rank 35%)
Frequently Asked Questions
Is STERIS plc (STE) a good investment?
What is STERIS plc's Piotroski F-Score?
Is STE overvalued or undervalued?
How does STE compare to other Health Care stocks?
What do investment models say about STE?
Similar Stocks
Compare STE with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer